CHF97.70
0.15%
SIX Swiss Exchange, Dec 30, 05:31 pm CET
ISIN
CH0360674466
Symbol
GALE

Galenica Target price 2026 - Analyst rating & recommendation

Galenica Classifications & Recommendation:

Hold
50%
Sell
50%

Galenica Price Target

Target Price CHF89.25
Price CHF97.70
Deviation
Number of Estimates 6
6 Analysts have issued a price target Galenica 2027 . The average Galenica target price is CHF89.25. This is lower than the current stock price. The highest price target is , the lowest is .
A rating was issued by 12 analysts: 0 Analysts recommend Galenica to buy, 6 to hold and 6 to sell.
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
Analyst Estimates: Analysts believe that the Galenica stock has an average upside potential 2027 of . Most analysts recommend the Galenica stock at Sell or hold.

Sales and Margin forecast 2025, 2026 to 2029

Create a premium account to unlock analyst estimates. Learn more

Dec '24 2025
Estimates
Revenue Billion CHF 3.92 4.22
4.67% 7.60%
EBITDA Margin 8.02% 8.02%
2.02% 0.05%
Net Margin 4.67% 4.51%
38.75% 3.34%

6 Analysts have issued a sales forecast Galenica 2025 . The average Galenica sales estimate is

CHF4.2b
Unlock
. This is
5.04% higher
Unlock
than the revenue of the last 12 months(TTM). The highest sales forecast is
CHF4.4b 8.65%
Unlock
, the lowest is
CHF4.0b 0.04%
Unlock
.

This results in the following potential growth metrics:

Revenue Estimates

2024 CHF3.9b 4.67%
2025
CHF4.2b 7.60%
Unlock
2026
CHF4.4b 4.79%
Unlock
2027
CHF4.6b 3.46%
Unlock
2028
CHF4.8b 5.12%
Unlock
2029
CHF5.0b 3.64%
Unlock

6 Analysts have issued an Galenica EBITDA forecast 2025. The average Galenica EBITDA estimate is

CHF338m
Unlock
. This is
3.90% higher
Unlock
than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is
CHF364m 11.65%
Unlock
, the lowest is
CHF286m 12.14%
Unlock
.

This results in the following potential growth metrics and future EBITDA Margins:

EBITDA Estimates

2024 CHF315m 6.79%
2025
CHF338m 7.55%
Unlock
2026
CHF365m 7.82%
Unlock
2027
CHF385m 5.45%
Unlock
2028
CHF383m 0.58%
Unlock
2029
CHF402m 5.18%
Unlock

EBITDA Margin

2024 8.02% 2.02%
2025
8.02% 0.05%
Unlock
2026
8.25% 2.87%
Unlock
2027
8.41% 1.94%
Unlock
2028
7.96% 5.35%
Unlock
2029
8.07% 1.38%
Unlock

6 Galenica Analysts have issued a net profit forecast 2025. The average Galenica net profit estimate is

CHF190m
Unlock
. This is
1.18% lower
Unlock
than the net profit for the last 12 months(TTM). The highest net profit forecast is
CHF201m 4.73%
Unlock
, the lowest is
CHF178m 7.40%
Unlock
.

This results in the following potential growth metrics and future Net Margins:

Net Profit Estimates

2024 CHF183m 35.89%
2025
CHF190m 3.89%
Unlock
2026
CHF204m 7.19%
Unlock
2027
CHF217m 6.43%
Unlock
2028
CHF241m 11.19%
Unlock
2029
CHF260m 7.81%
Unlock

Net Margin

2024 4.67% 38.75%
2025
4.51% 3.34%
Unlock
2026
4.61% 2.22%
Unlock
2027
4.74% 2.82%
Unlock
2028
5.01% 5.70%
Unlock
2029
5.22% 4.19%
Unlock

Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 to 2029

Create a premium account to unlock analyst estimates. Learn more

Dec '24 2025
Estimates
Earnings Per Share CHF 3.67 3.81
35.73% 3.81%
P/E 25.61
EV/Sales 1.34

6 Analysts have issued a Galenica forecast for earnings per share. The average Galenica EPS is

CHF3.81
Unlock
. This is
1.30% lower
Unlock
than earnings per share in the financial year 2024. The highest EPS forecast is
CHF4.04 4.66%
Unlock
, the lowest is
CHF3.57 7.51%
Unlock
.

This results in the following potential growth metrics and future valuations:

Earnings Per Share

2024 CHF3.67 35.73%
2025
CHF3.81 3.81%
Unlock
2026
CHF4.09 7.35%
Unlock
2027
CHF4.35 6.36%
Unlock
2028
CHF4.84 11.26%
Unlock
2029
CHF5.22 7.85%
Unlock

P/E ratio

Current 25.31 20.69%
2025
25.61 1.18%
Unlock
2026
23.90 6.68%
Unlock
2027
22.45 6.07%
Unlock
2028
20.19 10.07%
Unlock
2029
18.73 7.23%
Unlock

Based on analysts' sales estimates for 2025, the Galenica stock is valued at an EV/Sales of

and an P/S ratio of .

This results in the following potential growth metrics and future valuations:

EV/Sales

Current 1.41 17.50%
2025
1.34 4.79%
Unlock
2026
1.28 4.57%
Unlock
2027
1.24 3.34%
Unlock
2028
1.18 4.87%
Unlock
2029
1.14 3.51%
Unlock

P/S ratio

Current 1.21 23.15%
2025
1.15 4.79%
Unlock
2026
1.10 4.58%
Unlock
2027
1.06 3.34%
Unlock
2028
1.01 4.87%
Unlock
2029
0.98 3.52%
Unlock

Current Galenica Upgrades & Downgrades

Create a Premium account to unlock Upgrades/Downgrades. Learn more
Analyst Rating Action Date
RESEARCH PARTNERS AG
Locked
Locked
Locked Mar 13 2025
RESEARCH PARTNERS AG
Locked
Locked
Locked Oct 24 2024
Analyst Rating Date
Locked
RESEARCH PARTNERS AG:
Locked
Locked
Mar 13 2025
Locked
RESEARCH PARTNERS AG:
Locked
Locked
Oct 24 2024

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today